Among human breast cancer samples excluding HER2-enriched tumors, tumors with overexpression of WNT-related genes and a low mRNA level of BECN1 present a poorer prognosis, and they are primarily TNBC [50,51]. This evidence concerns the gene ERBB2 and breast carcinoma.